News for InflaRx N.V. (IFRX)

JENA, Germany, March 07, 2025 (GLOBE NEWSWIRE) -- InflaRx N.V. ( IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting the co

**media[553509]**

JENA, Germany, Feb. 28, 2025 (GLOBE NEWSWIRE) -- InflaRx N.V. ( IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting the com

JENA, Germany, Feb. 25, 2025 (GLOBE NEWSWIRE) -- InflaRx N.V. ( IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the

JENA, Germany, Feb. 18, 2025 (GLOBE NEWSWIRE) -- InflaRx N.V. ( IFRX) (the ”œCompany”), a biopharmaceutical company pioneering anti-inflammatory therapeuti

Texas-based Moleculin Biotech, Inc. (MBRX), a clinical stage pharmaceutical company is up over 53 percent in Friday's pre-market trading. The following are some of the other stocks making big moves in Friday's pre-market trading.

InflaRx N.V. (IFRX) announces a $2.00 pricing in its public offering, raising funds to advance pipeline candidates like vilobelimab.

**media[540475]**

**media[540320]**

San Francisco confirmed that a child in the city became the first case of H5N1. A panel of biotech leaders discussed what options could be taken next.

IFRX stock gains 8% on EC nod for Gohibic, under exceptional circumstances, to treat adult patients with COVID-19-induced ARDS.

InflaRx (IFRX) has received EU regulatory approval for its treatment Gohibic for the treatment of COVID-19 patients experiencing acute respiratory distress.

JENA, Germany, Jan. 15, 2025 (GLOBE NEWSWIRE) -- InflaRx N.V. ( IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting the com

JENA, Germany, Jan. 07, 2025 (GLOBE NEWSWIRE) -- InflaRx N.V. ( IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the

**media[497713]**

InflaRx's vilobelimab receives positive opinion from EU drug regulator for treating SARS-CoV-2-induced acute respiratory distress.

**media[467230]**

Clearside Biomedical names new board chair

Presentation of the proposed board members to the Annual General Meeting on 13 May 2024 Jesper Høiland - born 1960, chairman Education:...